What is new in cancer-associated fibroblast biomarkers?

Paget S. The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastasis Rev. 1989;8(2):98–101.

CAS  PubMed  Google Scholar 

Bhowmick NA, Neilson EG, Moses HL. Stromal fibroblasts in cancer initiation and progression. Nature. 2004;432(7015):332–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ganguly D, Chandra R, Karalis J, Teke M, Aguilera T, Maddipati R, Wachsmann MB, Ghersi D, Siravegna G, Zeh HJ, Brekken R, Ting DVT, Ligorio M. Cancer-associated fibroblasts: versatile players in the tumor microenvironment. Cancers. 2020;12(9):34.

Article  Google Scholar 

Madar S, Goldstein I, Rotter V. “Cancer associated fibroblasts” - more than meets the eye. Trends Mol Med. 2013;19(8):447–53.

Article  CAS  PubMed  Google Scholar 

Peltier A, Seban R-D, Buvat I, Bidard F-C, Mechta-Grigoriou F. Fibroblast heterogeneity in solid tumors: From single cell analysis to whole-body imaging. Semin Cancer Biol. 2022;86(Pt 3):262–72.

Article  CAS  PubMed  Google Scholar 

Han CC, Liu TY, Yin R. Biomarkers for cancer-associated fibroblasts. Biomark Res. 2020;8(1):8.

Article  Google Scholar 

Gong C, Nie Y, Qu SH, Liao JY, Cui XY, Yao HR, Zeng YJ, Su FX, Song EW, Liu Q. miR-21 induces myofibroblast differentiation and promotes the malignant progression of breast phyllodes tumors. Can Res. 2014;74(16):4341–52.

Article  CAS  Google Scholar 

Calvete J, Larrinaga G, Errarte P, Martin AM, Dotor A, Esquinas C, Nunes-Xavier CE, Pulido R, Lopez JI, Angulo JC. The coexpression of fibroblast activation protein (FAP) and basal-type markers (CK 5/6 and CD44) predicts prognosis in high-grade invasive urothelial carcinoma of the bladder. Hum Pathol. 2019;91:61–8.

Article  CAS  PubMed  Google Scholar 

An JL, Hou DK, Wang L, Wang LL, Yang YY, Wang HT. Fibroblast activation protein-alpha knockdown suppresses prostate cancer cell invasion and proliferation. Histol Histopath. 2022;37(6):597–607.

CAS  Google Scholar 

Liu JY, Huang CQ, Peng CW, Xu F, Li Y, Yutaka Y, Xiong B, Yang XJ. Stromal fibroblast activation protein alpha promotes gastric cancer progression via epithelial-mesenchymal transition through Wnt/beta-catenin pathway. BMC Cancer. 2018;18:10.

Article  Google Scholar 

Goscinski MA, Suo Z, Florenes VA, Vlatkovic L, Nesland JM, Giercksky KE. FAP-alpha and uPA show different expression patterns in premalignant and malignant esophageal lesions. Ultrastruct Pathol. 2008;32(3):89–96.

Article  PubMed  Google Scholar 

Errarte P, Guarch R, Pulido R, Blanco L, Nunes-Xavier CE, Beitia M, Gil J, Angulo JC, Lopez JI, Larrinaga G. The expression of fibroblast activation protein in clear cell renal cell carcinomas is associated with synchronous lymph node metastases. PLoS ONE. 2016;11(12):13.

Article  Google Scholar 

Sun LY, Ke ML, Wang X, Yin MY, Wei JN, Xu L, Tian X, Wang F, Zhang H, Fu SB, Zhang CY. FAP(high) alpha-SMA(low) cancer-associated fibroblast-derived SLPI protein encapsulated in extracellular vesicles promotes ovarian cancer development via activation of PI3K/AKT and downstream signaling pathways. Mol Carcinog. 2022;61(10):910–23.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhao Y, Liu Y, Jia Y, Wang X, He J, Zhen S, Wang J, Liu L. Fibroblast activation protein in the tumor microenvironment predicts outcomes of PD-1 blockade therapy in advanced non-small cell lung cancer. J Cancer Res Clin Oncol. 2022. https://doi.org/10.1007/s00432-022-04250-4.

Sun LL, Schroeder MC, Hagemann IS, Pfeifer JD, Schwarz JK, Grigsby PW, Markovina S, Lin AJ. Expression of potential biomarker targets by immunohistochemistry in cervical carcinomas. Int J Gynecol Pathol. 2022;41(6):628–35.

Article  CAS  PubMed  Google Scholar 

Tong Y, Zhao Z, Zhang J, Wang W, Zhu Y. High expressions of CD10, FAP and GPR77 in CAFs are associated with chemoresistance and worse prognosis in gastric cancer. Front Oncol. 2022;12:984817.

Article  PubMed  PubMed Central  Google Scholar 

Qi JJ, Sun HX, Zhang Y, Wang ZT, Xun ZZ, Li ZY, Ding XY, Bao RJ, Hong LW, Jia WQ, Fang F, Liu HZ, Chen L, Zhong J, Zou DW, Liu LX, Han L, Ginhoux F, Liu YB, Ye YQ, Su B. Single-cell and spatial analysis reveal interaction of FAP(+) fibroblasts and SPP1(+) macrophages in colorectal cancer. Nat Commun. 2022;13(1):20.

Article  Google Scholar 

Wen XY, He XP, Jiao F, Wang CH, Sun Y, Ren XQ, Li QW. Fibroblast activation protein-alpha-positive fibroblasts promote gastric cancer progression and resistance to immune checkpoint blockade. Oncol Res. 2017;25(4):629–40.

Article  PubMed  PubMed Central  Google Scholar 

Rong XX, Lv JY, Liu YT, Wang ZJ, Zeng DQ, Li YD, Li SW, Wu JH, Shen ZY, Shi M, Liao WJ, Wu ZZ, Wang CL. PET/Ct imaging of activated cancer-associated fibroblasts predict response to PD-1 blockade in gastric cancer patients (vol 11, 802257, 2022). Front Oncol. 2022;12:1.

Article  Google Scholar 

Costa A, Kieffer Y, Scholer-Dahirel A, Pelon F, Bourachot B, Cardon M, Sirven P, Magagna I, Fuhrmann L, Bernard C, Bonneau C, Kondratova M, Kuperstein I, Zinovyev A, Givel AM, Parrini MC, Soumelis V, Vincent-Salomon A, Mechta-Grigoriou F. Fibroblast heterogeneity and immunosuppressive environment in human breast cancer. Cancer Cell. 2018;33(3):463.

Article  CAS  PubMed  Google Scholar 

Feig C, Jones JO, Kraman M, Wells RJB, Deonarine A, Chan DS, Connell CM, Roberts EW, Zhao Q, Caballero OL, Teichmann SA, Janowitz T, Jodrell DI, Tuveson DA, Fearon DT. Targeting CXCL12 from FAP-expressing carcinomaassociated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer. Proc Natl Acad Sci USA. 2013;110(50):20212–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lin YL, Li BJ, Yang XG, Cai Q, Liu WR, Tian MX, Luo HY, Yin W, Song Y, Shi YH, He R. Fibroblastic FAP promotes intrahepatic cholangiocarcinoma growth via MDSCs recruitment. Neoplasia. 2019;21(12):1133–42.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Scott AM, Wiseman G, Welt S, Adjei A, Lee FT, Hopkins W, Divgi CR, Hanson LH, Mitchell P, Gansen DN, Larson SM, Ingle JN, Hoffman EW, Tanswell P, Ritter G, Cohen LS, Bette P, Arvay L, Amelsberg A, Vlock D, Rettig WJ, Old LJ. A phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer. Clin Cancer Res. 2003;9(5):1639–47.

CAS  PubMed  Google Scholar 

Welt S, Divgi CR, Scott AM, Garin-Chesa P, Finn RD, Graham M, Carswell EA, Cohen A, Larson SM, Old LJ. Antibody targeting in metastatic colon cancer: a phase I study of monoclonal antibody F19 against a cell-surface protein of reactive tumor stromal fibroblasts. J Clin Oncol. 1994;12(6):1193–203.

Article  CAS  PubMed  Google Scholar 

Fang JX, Xiao L, Joo KI, Liu YR, Zhang CP, Liu SL, Conti PS, Li ZB, Wang P. A potent immunotoxin targeting fibroblast activation protein for treatment of breast cancer in mice. Int J Cancer. 2016;138(4):1013–23.

Article  CAS  PubMed  Google Scholar 

Kraman M, Bambrough PJ, Arnold JN, Roberts EW, Magiera L, Jones JO, Gopinathan A, Tuveson DA, Fearon DT. Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha. Science. 2010;330(6005):827–30.

Article  CAS  PubMed  Google Scholar 

Santos AM, Jung J, Aziz N, Kissil JL, Pure E. Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice. J Clin Invest. 2009;119(12):3613–25.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Adams S, Miller GT, Jesson MI, Watanabe T, Jones B, Wallner BP. PT-100, a small molecule dipeptidyl peptidase inhibitorg has potent antitumor effects and augments antibody-mediated cytotoxicity via a novel immune mechanism. Can Res. 2004;64(15):5471–80.

Article  CAS  Google Scholar 

Loeffler M, Kruger JA, Niethammer AG, Reisfeld RA. Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake. J Clin Invest. 2006;116(7):1955–62.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang LCS, Lo A, Scholler J, Sun J, Majumdar RS, Kapoor V, Antzis M, Cotner CE, Johnson LA, Durham AC, Solomides CC, June CH, Pure E, Albelda SM. Targeting fibroblast activation protein in tumor stroma with chimeric antigen receptor T cells can inhibit tumor growth and augment host immunity without severe toxicity. Cancer Immunol Res. 2014;2(2):154–66.

Article  CAS  PubMed  Google Scholar 

Kakarla S, Chow KKH, Mata M, Shaffer DR, Song XT, Wu MF, Liu H, Wang LL, Rowley DR, Pfizenmaier K, Gottschalk S. Antitumor effects of chimeric receptor engineered human T cells directed to tumor stroma. Mol Ther. 2013;21(8):1611–20.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mezawa Y, Orimo A. The roles of tumor- and metastasis-promoting carcinoma-associated fibroblasts in human carcinomas. Cell Tissue Res. 2016;365(3):675–89.

Article  CAS  PubMed  Google Scholar 

Bu L, Baba H, Yoshida N, Miyake K, Yasuda T, Uchihara T, Tan P, Ishimoto T. Biological heterogeneity and versatility of cancer-associated fibroblasts in the tumor microenvironment. Oncogene. 2019;38(25):4887–901.

Article  CAS  PubMed  Google Scholar 

Weber CE, Kothari AN, Wai PY, Li NY, Driver J, Zapf MAC, Franzen CA, Gupta GN, Osipo C, Zlobin A, Syn WK, Zhang J, Kuo PC, Mi Z. Osteopontin mediates an MZF1-TGF-beta 1-dependent transformation of mesenchymal stem cells into cancer-associated fibroblasts in breast cancer. Oncogene. 2015;34(37):4821–33.

Article  CAS  PubMed  Google Scholar 

Fujita H, Ohuchida K, Mizumoto K, Nakata K, Yu J, Kayashima T, Cui L, Manabe T, Ohtsuka T, Tanaka M. alpha-smooth muscle actin expressing stroma promotes an aggressive tumor biology in pancreatic ductal adenocarcinoma. Pancreas. 2010;39(8):1254–62.

Article  CAS  PubMed 

留言 (0)

沒有登入
gif